LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,613,505 | -4.9% | 924,170 | 0.0% | 0.38% | -37.4% |
| Q2 2023 | $3,798,339 | +104.5% | 924,170 | 0.0% | 0.61% | +67.2% |
| Q1 2023 | $1,857,582 | -36.0% | 924,170 | 0.0% | 0.36% | -25.8% |
| Q4 2022 | $2,901,894 | -37.3% | 924,170 | 0.0% | 0.49% | -31.5% |
| Q3 2022 | $4,630,000 | -11.3% | 924,170 | 0.0% | 0.71% | -30.5% |
| Q2 2022 | $5,222,000 | – | 924,170 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|